Azienda Ospedaliera Brotzu Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT01561846
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

cyclophosphamide (cytoxan) (1 trial)

methylprednisolone (medrol) (1 trial)

rituximab (rituxan) (1 trial)

Drugs in Phase 2 Trials (1)

conjugated linoleic acid (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glomerulonephritis (Phase 3)

Glomerulonephritis, Membranous (Phase 3)

Hypercholesterolemia (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4